Resultados de la búsqueda 111-120 of 7621 for Nutrients

  1. Estar en forma - Mayo Clinic

    News. septiembre 2024. Perimenopause, menopause and ... weightlifting? Expert explains value for bone health Sept. 04, 2024, 03:15 p.m. CDT ...

  2. comer frutos secos para la salud del corazón - Mayo Clinic

    Nutrients. 2020; doi:10.3390/nu12030682. Healthy diet (adult). AskMayoExpert. Mayo Clinic; 2022. English walnut. Natural Medicines. https://naturalmedicines ...

  3. Nutrición y comida saludable LGBTQ health - Mayo Clinic

    https://www.eatright.org/health/essential-nutrients/supplements/vitamins-minerals-and-supplements-do-you-need-to-take-them. Accessed June 22, 2023 ...

  4. Ensayos clínicos - Medicina interna general

    ... nutrients.Subsequently, look at the effects of Ondansetron on these patients' symptoms. A Study to Assess Markers of Aging Process. Rochester, Minn. The ...

  5. Nutrición y comida saludable Sleep - Mayo Clinic

    https://www.eatright.org/health/essential-nutrients/supplements/vitamins-minerals-and-supplements-do-you-need-to-take-them. Accessed June 22, 2023 ...

  6. Ensayos clínicos - Medicina interna general

    ... nutrients.Subsequently, look at the effects of Ondansetron on these patients' symptoms. A Study to Assess Markers of Aging Process. Rochester, Minn. The ...

  7. Nutrición y comida saludable - Mayo Clinic

    https://www.eatright.org/health/essential-nutrients/supplements/vitamins-minerals-and-supplements-do-you-need-to-take-them. Accessed June 22, 2023 ...

  8. Vitamina B-12 y depresión: ¿Están relacionadas? - Mayo Clinic

    Dietary nutrient deficiencies and risk of depression (review article 2018-2023). Nutrients. 2023; doi:10.3390/nu15112433. Vitamin B12: Fact sheet for health ...

  9. Vitamina B-12 y depresión: ¿Están relacionadas? - Mayo Clinic

    Dietary nutrient deficiencies and risk of depression (review article 2018-2023). Nutrients. 2023; doi:10.3390/nu15112433. Vitamin B12: Fact sheet for health ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...